Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Offering drug development solutions from preclinical through commercialization, Covance is a world-class provider of the following service lines:
Research products
Antibody products and services
Nonclinical development services
Risk management services
Clinical pharmacology services
Central laboratory/Covance local laboratory services
Cardiac safety services
Clinical development services
Commercialization services
Covance — Meeting Your Needs
With a commitment to meeting your needs, Covance offers unparalleled expertise, experience and results. Covance knows the significant pressures pharmaceutical and biotechnology companies of all sizes face in developing and launching drugs backed by strong data.
With a business built around your needs, our streamlined approach to drug development means high quality, error-free data designed to help bring your drug to market as quickly, safely and cost effectively as possible, including:
Proving early safety
Conducting first in human studies
Conducting proof of concept studies
Proving clinical safety and efficacy
Filing for marketing approval
Launching and marketing a drug
Ensuring patient safety and access
Managing risk
Managing over 15,000 clinical trial protocols in 100 countries on 6 continents, Covance provides the experience and exceptional customer service to advance your compound along the drug development continuum. Strategic partnerships built on decades of success — Covance is dedicated to helping bring your miracles to market sooner.
United States
